T. Rowe Price Associates
ATYR

T. Rowe Price Associates’s aTyr Pharma ATYR Stock Holding History

T. Rowe Price Associates’s Portfolio ATYR Stock Details ATYR Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$34K Buy
2025
Q2 		$221K Buy
2021
Q4 		– Sell
2021
Q3 		$109K Buy
2016
Q2 		– Sell
2016
Q1 		$2.05M Sell
2015
Q4 		$11.5M Sell
2015
Q3 		$11.8M Sell
2015
Q2 		$21.4M Buy